Skip to main content
OpenTrials

Clinical trial condition

Hepatic Impaired

Explore clinical trials studying Hepatic Impaired. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Hepatic Impaired trial results

Completed

Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

NCT02210871

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
Locations
  • Novo Nordisk Investigational Site Warsaw, Poland
  • Novo Nordisk Investigational Site Wołomin, Poland
  • Novo Nordisk Investigational Site Bratislava, Slovakia
  • Novo Nordisk Investigational Site Bratislava, Slovakia
View Trial Details

Related conditions